The appearance of antibody to hepatitis B core antigen (anti-HBc) during acute hepatitis B infection has been clearly documented in both man (Hoofnagle et al., 1973) and the chimpanzee (Markenson et al., 1975) . It has also been found that antibody is regularly present in the sera of established carriers (Hoofnagle et al., 1973) . It therefore seems that determination of anti-HBc might provide a sensitive indication of active or recent hepatitis B infection, but so far its application in routine laboratories has been very limited.
Several methods for detecting anti-HBc have been described, including fluorescent antibody (Brzosko et al., 1973) , complement fixation (Hoofnagle et al., 1973) , immunoelectro-osmophoresis (Budkowska et al., 1974) , and radio-immune precipitation (Moritsugu et al., 1975 (Pesendorfer et al., 1970) . Screening tests for anti-HBc were carried out using both the 'partially purified' HBcAg (used at two to four times its IEOP titre) and 'normal' antigen control prepared from HBsAg negative liver tissue. All positive reactions were confirmed with CsCl gradient purified HBcAg, and selected reactions were further checked by electron microscopy of the precipitin line (Fig. 1) . Complement fixation (CF) (Grist et al., 1975) and immune electron microscopy (IEM) (Almeida et al., 1969) were performed by conventional methods.
HBsAg and anti-HBs tests were performed by IEOP and radioimmunoassay (RIA) using commercially available reagents (Abbott Laboratories). HBeAg and anti-HBe were detected by immunodiffusion (Magnius and Espmark, 1972 . a z -: (Fig. 4) .
Of 66 patients with HBsAg-negative chronic liver disease 14 reacted in the IEOP screening test but the titres were low (Fig. 4) . Results of confirmatory tests on the 14 sera are shown in Table 3 . Because a high proportion (65 %) of these patients were antiHBs positive all the group were tested (Table 4) . A much lower proportion (13 %) of the anti-HBc negative group was anti-HBs positive but this is still higher than the 6 % level found in normal adults in this country (Cossart, 1976) .
Discussion
This study was undertaken firstly to establish the practicability of routine tests for anti-HBc and secondly to assess their value in clinical practice.
An electrophoresis test was chosen because many hepatitis laboratories have considerable experience with this method which is simple, quick, and economical. The problem of producing a substantial amount of HBcAg was solved by obtaining livers from postmortem examinations on HBsAg-positive subjects. Two of 24 were suitable, that is, contained abundant HBcAg but scanty HBsAg in patients with little, or no, detectable anti-HBc. In our experience, this combination was found only in the two patients who yielded the antigen preparations used for the tests. They were both heavily immunosuppressed.
The crude antigen from the simple extraction procedure was almost as satisfactory as the more highly purified one but both gave some non-specific precipitin lines in which antibody-coated cores could not be found by electron microscopy. A control antigen extracted from a normal liver also gave lines with some of the false positive sera, which were rare among blood donors (0-1 %) but frequent in patients with acute hepatitis (30 %) and not uncommon in chronic hepatitis (6 %). Similar non-specific reactions have been reported when sera from the acute phase of hepatitis have been tested against other antigens (Almeida et al., 1974 A larger study of anti-HBc tests for screening blood donors is needed. Our results suggest that it is much cheaper, simpler, and quicker than radioimmunoassay or enzyme-immunoassay for HBsAg, yet it detected all the hepatitis B carriers detected by these cumbersome methods. It is not known whether persons with anti-HBc who are HBsAg-negative are infective. We were unable to obtain specimens from the four patients transfused with material in this category, but it was possible to establish that none developed clinical hepatitis during the ensuing nine months.
It is difficult to interpret the anti-HBc results in patients with HBs-Ag-negative chronic liver disease since little was known about their country of origin or previous history. However, they certainly differ from the general population as regards presence of both anti-HBs (23 % positive; compared with normal 6 %) and anti-HBc (21 % positive; compared with 0-75 % normal). This suggests that hepatitis B infection may have been the initial liver injury in a significant proportion of these patients.
In general, our findings show that routine anti-HBc tests can be introduced relatively easily, and that they offer useful additional information about patients with suspected hepatitis B infection. 
